Cabot Corp. (CBT) — Fair Value Analysis
Base-case fair value (P50): $120.52 · Current price: $85.61 · Verdict: Undervalued
The Verdict on CBT
Based on our proprietary Monte Carlo simulations, CABOT CORP (CBT) appears deeply undervalued. Our analysis indicates a median fair value (P50) of $120.52 against its current trading price of $85.61. This suggests a substantial potential upside of +40.8% for investors. The robust Monte Carlo methodology explores thousands of forward-looking financial scenarios, allowing for a comprehensive assessment of CBT's intrinsic value, factoring in various market dynamics and company-specific variables. The significant gap between the current market price and our fair value estimate points to a compelling investment opportunity.
How CBT stacks up against peers
CABOT CORP (CBT) demonstrates average operational and financial health when benchmarked against its sector peers. This average quality tier suggests a stable foundation without significant red flags, yet also without exceptional outperformance in its core metrics relative to the industry. Despite this average standing in terms of quality, the substantial +40.8% identified by our simulations highlights a disconnect between the market’s perception (reflected in $85.61) and CBT's intrinsic value. An average quality tier company with such a pronounced undervaluation warrants closer inspection, especially given the P50 target of $120.52.
What this means for investors
For investors considering CABOT CORP, the current market price of $85.61 presents a notable discount to our estimated median fair value of $120.52. The Monte Carlo simulation framework, which underpins this +40.8% assessment, provides a probabilistic view of CBT's future performance. While our analysis indicates a strong upside, investors should always consider their own risk tolerance. FairCurve subscribers gain access to the full spectrum of our Monte Carlo output, including the P10 bear case and P90 bull case scenarios, offering a complete picture of potential outcomes. Sign up for FairCurve today to see the full bear/bull distribution and track CBT's fair value as new fundamentals are released.
Frequently Asked Questions
Is CBT overvalued or undervalued right now?
Based on our Monte Carlo simulations, CABOT CORP (CBT) is deeply undervalued. Our median fair value (P50) estimate of $120.52 significantly exceeds its current price of $85.61.
What is the bear case and bull case for CBT?
The full Monte Carlo distribution, including the P10 bear case and P90 bull case targets, alongside the probability of upside, is exclusively available to users with a free FairCurve account. We do not provide specific dollar values for these scenarios outside of the platform.
How does FairCurve calculate CBT's fair value?
FairCurve calculates CBT's fair value using a robust Monte Carlo simulation, exploring thousands of forward financial scenarios to arrive at a probabilistic range of outcomes. This methodology does not rely on simple multiples but rather a comprehensive model of future cash flows.
How can I track CBT's fair value as it changes?
You can add CBT to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings or fundamental data are released, ensuring you always have the latest assessment.